Search - tctmd.com

Displaying 601 - 620 of 1375

Sort: Relevancy | Date

Presentation TCT 2019

When and How to Debulk Bifurcation Lesion?

Presenter: Alaide Chieffo

September 26, 2019

Presentation TCT 2019

Germany Presents: Ostium Occlusion of Right Coronary Artery — Complex Retrograde Recanalization With Rotablation

Presenter: Jochen Wohrle

September 26, 2019

Presentation TCT 2019

How Do I Approach Non-Left Main Bifurcation Branch Ostial Lesions?

Presenter: Hyeon-Cheol Gwon

September 26, 2019

Presentation TCT 2019

Colombia Presents: Aortic Valve Trauma as a Complication in Young Patient With Spontaneous Coronary Dissection

Presenter: Jorge Villegas

September 26, 2019

Presentation TCT 2019

How to Deal With Difficult Non-Left Main Bifurcation Anatomies: Side Branch Access Techniques

Presenter: Philippe Garot

September 26, 2019

Presentation TCT 2019

When IVUS-OCT Guidance is a Need: Highly Calcified Lesions and ACS

Presenter: Francesco Prati

September 26, 2019

Presentation TCT 2019

Can We and Should We Use FFR/IFR/qFR to Guide the Bifurcation Strategy?

Presenter: Bon-Kwon Koo

September 26, 2019

Presentation TCT 2019

When Is a Side Branch Clinically Relevant?

Presenter: Yves Louvard

September 26, 2019

Presentation TCT 2019

IVUS/OCT Guidance of Non-LM Bifurcation Stenting: When and How to Use it in Practice

Presenter: Yoshinobu Onuma

September 26, 2019

Presentation TCT 2019

Ultrathin Orsiro: Where It Can Go

Presenter: Steven Yakubov

September 26, 2019

Presentation TCT 2019

FDA Pivotal Clinical Trial Design and Beyond

Presenter: Ori Ben-Yehuda

September 26, 2019

Presentation TCT 2019

Use of Sirolimus-Coated Balloon (MagicTouch) in Coronary Intervention: Data and Case Examples From a Real-World Population

Presenter: Sandeep Basavarajaiah

September 26, 2019

News TCT 2019

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

Shelley Wood

September 26, 2019

Presentation TCT 2019

A Personal Perspective: Why I Choose Orsiro in STEMI

Presenter: Juan Fernando Iglesias

September 26, 2019

Presentation TCT 2019

Real-World Data From EASTBOURNE to TRANSFORM Trials

Presenter: Bernardo Cortese

September 26, 2019

Presentation TCT 2019

First Experience With FDA-Approved Orsiro in the USA

Presenter: Farouc Jaffer

September 26, 2019

Presentation TCT 2019

First-in-Man: Brazil ISR Experience With Angiographic and IVUS Results

Presenter: Alexandre Abizaid

September 26, 2019

Presentation TCT 2019

Why SEB Should Be Safer: Insights From Preclinical Study

Presenter: Aloke Finn

September 26, 2019

Presentation TCT 2019

TWILIGHT Thrombogenicity Substudy: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin on Ex-Vivo Blood Thrombogenicity in High-Risk Patients Undergoing PCI

Presenter: Usman Baber

September 26, 2019

Presentation TCT 2019

Delivering Evidence

Presenter: James Hermiller

September 26, 2019

Advertisement

When and How to Debulk Bifurcation Lesion?

Germany Presents: Ostium Occlusion of Right Coronary Artery — Complex Retrograde Recanalization With Rotablation

How Do I Approach Non-Left Main Bifurcation Branch Ostial Lesions?

Colombia Presents: Aortic Valve Trauma as a Complication in Young Patient With Spontaneous Coronary Dissection

How to Deal With Difficult Non-Left Main Bifurcation Anatomies: Side Branch Access Techniques

When IVUS-OCT Guidance is a Need: Highly Calcified Lesions and ACS

Can We and Should We Use FFR/IFR/qFR to Guide the Bifurcation Strategy?

When Is a Side Branch Clinically Relevant?

IVUS/OCT Guidance of Non-LM Bifurcation Stenting: When and How to Use it in Practice

Ultrathin Orsiro: Where It Can Go

FDA Pivotal Clinical Trial Design and Beyond

Use of Sirolimus-Coated Balloon (MagicTouch) in Coronary Intervention: Data and Case Examples From a Real-World Population

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

A Personal Perspective: Why I Choose Orsiro in STEMI

Real-World Data From EASTBOURNE to TRANSFORM Trials

First Experience With FDA-Approved Orsiro in the USA

First-in-Man: Brazil ISR Experience With Angiographic and IVUS Results

Why SEB Should Be Safer: Insights From Preclinical Study

TWILIGHT Thrombogenicity Substudy: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin on Ex-Vivo Blood Thrombogenicity in High-Risk Patients Undergoing PCI

Delivering Evidence

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content